Better outcomes
Guide more effective medication selection across diverse member populations.
When plan members are on the wrong medications, everyone pays.
Managing medications for illness or disability can be complex, ineffective, and costly. Inagene helps identify medication-related barriers to recovery — reducing drug spend waste, shortening disability claims, and giving prescribers the information they need to get it right sooner.
Inagene fully owns and operates its Canadian PGx lab, independently accredited for the highest quality and data security standards.
>99% of people have gene variants that impact their response to at least one commonly used medication
Plan members and their prescribers rely on medications to manage their increasing number of complex illnesses and disabilities. But in many cases, they are left guessing as to which medications will work, which won't work at all, and which may even cause harm.
Inagene provides a roadmap to the information in your genes, uncovering how different people respond to medications. With just a cheek swab, genetic material is analyzed and measured for its response to medications prescribed for numerous conditions. The result is a clear, clinically actionable report that informs every relevant prescribing decision going forward.
Optimize your drug spend
Lower plan costs
Reduce drug spend from ineffective prescriptions and shorten costly disability claims.
Built to complement - not replace
Embeds into existing care pathways with account management built in.
Who We Help
Disability Management
Give case managers a clinical tool for when medication may be stalling recovery.
Benefits Consultants
Bring plan sponsors a differentiated solution that moves the needle on cost.
Plan Sponsors
Reduce drug spend and disability costs driven by medication trial-and-error.
Healthcare Providers
Make more confident prescribing decisions with genetic insight.
Payors & Administrators
Turn PGx coverage into realized clinical and financial value.
Ways We Help
Mental Health
Mental health diagnoses and medication use are on the rise and are the leading driver of disability claims in Canadian benefit plans. Yet many commonly prescribed medications don’t work as expected, because genetics determine how a person responds.
Women’s Health
Canadian women spend 24 percent more of their lives in poor health than men, a gap that shows up in disability claims, benefit costs and workforce participation. Many of the medications used to address women’s health conditions have significant genetic variability in how they’re processed.
Cardiovascular Health
Blood thinners, statins, and blood pressure medications are among the most commonly prescribed drugs in Canada, and genetic variation significantly affects how they're metabolized. For members on these medications who aren't responding as expected, there is a risk in unmanaged cardiovascular disease that shows up downstream in claims, complications, and disability.
Chronic Pain
Chronic pain accounts for approximately 10% of top diagnoses in Canadian employee benefit plans. When pain medications aren’t working as expected, members stay on leave longer, cycle through more prescriptions, and cost the plan more — often for reasons that are genetically detectable.
Precision prescribing isn't just a trend - it's proven
more likely to achieve remission with PGx-guided prescribing for patients suffering from major depressive disorder
(based on peer-reviewed clinical research)
3.3 years
average avoidable trial-and-error medication time per patient
(based on a Calian Health pilot study)
98%
of patients avoided side effects or had shorter absences after following Inagene PGx recommendations
(based on a Calian Health pilot study)
$3,008
average per-patient savings projected over three years with Inagene PGx
(based on a Calian Health pilot study)
1000s
of Canadians tested
100s
of HCPs already using Inagene results to guide prescribing
"About 80% of my patients have had to deal with trial and error in at least one or more of their medications, particularly with antidepressants, but also cholesterol, migraine, birth control and hormone therapy. It's very prevalent."
About Inagene
Inagene has been advancing pharmacogenetic testing in Canada for nearly a decade, building the country's most comprehensive PGx panel, operating a fully-owned, Canadian PGx lab, and making clinically rigorous genetic guidance accessible to plan members and their care teams.